These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11309276)

  • 1. Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer.
    Sasaki M; Kotcherguina L; Dharia A; Fujimoto S; Dahiya R
    Cancer Res; 2001 Apr; 61(8):3262-6. PubMed ID: 11309276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
    Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
    Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
    Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
    Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
    Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
    J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG methylation of the ERalpha and ERbeta genes in breast cancer.
    Kim SJ; Kim TW; Lee SY; Park SJ; Kim HS; Chung KW; Lee ES; Kang HS
    Int J Mol Med; 2004 Aug; 14(2):289-93. PubMed ID: 15254780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.
    Sasaki M; Tanaka Y; Perinchery G; Dharia A; Kotcherguina I; Fujimoto Si; Dahiya R
    J Natl Cancer Inst; 2002 Mar; 94(5):384-90. PubMed ID: 11880477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma.
    Shiozawa T; Itoh K; Horiuchi A; Konishi I; Fujii S; Nikaido T
    Anticancer Res; 2002; 22(1A):139-43. PubMed ID: 12017277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
    Takai N; Kawamata N; Walsh CS; Gery S; Desmond JC; Whittaker S; Said JW; Popoviciu LM; Jones PA; Miyakawa I; Koeffler HP
    Mol Cancer Res; 2005 May; 3(5):261-9. PubMed ID: 15886297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
    Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
    Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter CpG methylation of oestrogen receptors in leukaemia.
    Yao J; Huang Q; Zhang XB; Fu WL
    Biosci Rep; 2009 Aug; 29(4):211-6. PubMed ID: 18808365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression.
    Li LC; Chui R; Nakajima K; Oh BR; Au HC; Dahiya R
    Cancer Res; 2000 Feb; 60(3):702-6. PubMed ID: 10676656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers.
    Sasaki M; Kaneuchi M; Fujimoto S; Tanaka Y; Dahiya R
    Mol Cell Endocrinol; 2003 Apr; 202(1-2):201-7. PubMed ID: 12770752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.
    Monroe DG; Getz BJ; Johnsen SA; Riggs BL; Khosla S; Spelsberg TC
    J Cell Biochem; 2003 Oct; 90(2):315-26. PubMed ID: 14505348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
    Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS
    Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5' end of the ER gene.
    Navari JR; Roland PY; Keh P; Salvesen HB; Akslen LA; Iversen OE; Das S; Kothari R; Howey S; Phillips B
    Clin Cancer Res; 2000 Oct; 6(10):4026-32. PubMed ID: 11051252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of hypermethylated DNA in two promoter regions of the estrogen receptor alpha gene in human endometrial diseases.
    Hori M; Iwasaki M; Shimazaki J; Inagawa S; Itabashi M
    Gynecol Oncol; 2000 Jan; 76(1):89-96. PubMed ID: 10620447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues].
    Liao QP; Wu C; Zheng H; Yu L
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):752-5. PubMed ID: 16324249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.
    Kaneuchi M; Sasaki M; Tanaka Y; Shiina H; Verma M; Ebina Y; Nomura E; Yamamoto R; Sakuragi N; Dahiya R
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1156-62. PubMed ID: 15044106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status.
    Cioppi F; Simi L; Luciani P; Petraglia F; Susini T; Cobellis L; Serio M; Maggi M; Peri A
    Oncol Rep; 2004 Feb; 11(2):427-33. PubMed ID: 14719079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
    Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
    Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.